Demystifying Medical Marijuana in New York | the New School for Social Research

Demystifying Medical Marijuana in New York | The New School for Social Research – Demystifying Medical Marijuana in New York: Implications for Mental Health and Drug Treatment Providers The New School for Social Research based in New York …

New test for Down syndrome

Filed under: drug treatment programs washington dc

… a drug on the market, and Associate Professor of Medicine Robert Green, director of the G2P Research Program at Harvard-affiliated Brigham and Women's Hospital. The event was affected by the ongoing budget controversy in Washington, D.C. One of the …
Read more on Harvard Gazette

Dimension, Backed by Fidelity, Targets Hemophilia With Gene Therapy

Filed under: drug treatment programs washington dc

Cambridge, MA-based Dimension was formed today through a collaboration between Fidelity BioSciences and Washington, D.C.-based Regenx Biosciences, and an undisclosed Series A round from Fidelity Biosciences. … “We have an approved drug now in Europe …
Read more on Xconomy

Study questions US FDA's shorter drug approval times

Filed under: drug treatment programs washington dc

Washington DC, USA (Reuters) – New drugs that receive expedited review by the Food and Drug Administration are being tested on fewer patients, leaving many safety questions unanswered even after they are approved, a study released on Monday in the …
Read more on Solar News